Impact of Delayed HIV Diagnosis and Treatment on Dementia Risk in Later Life - Report - MDSpire

Impact of Delayed HIV Diagnosis and Treatment on Dementia Risk in Later Life

  • By

  • Jennifer O Lam

  • Catherine Lee

  • Craig E Hou

  • Dongjie Fan

  • Haihong Hu

  • Errol Lopez

  • Alexandra Lea

  • William J Towner

  • Michael A Horberg

  • Michael J Silverberg

  • January 22, 2026

  • 0 min

Share

Impact of Delayed HIV Diagnosis on Dementia Risk in Older Adults

Overview

In a large retrospective cohort study of adults with HIV aged 50 and older, a low CD4 count (<200 cells/µL) prior to antiretroviral therapy initiation was associated with a 33% increased risk of developing dementia. Although CD4 recovery after ART initiation reduced this risk, it did not fully eliminate it, highlighting the lasting effects of delayed HIV diagnosis or treatment on cognitive health.

Background

As people with HIV live longer due to effective antiretroviral therapy (ART), age-related cognitive decline and dementia have become significant concerns. HIV can enter the central nervous system early in infection, causing neurocognitive disorders, and low nadir CD4 counts have been linked to brain atrophy and cognitive impairment. While ART reduces severe HIV-associated neurocognitive disorders, milder impairments persist, potentially due to legacy effects of early immunosuppression. The influence of delayed HIV diagnosis or treatment on age-associated dementia risk has not been previously well studied.

Data Highlights

CharacteristicValue
Sample size21,354 adults with HIV aged ≥50 years
Mean age54 years
Gender87% men
Race/Ethnicity46% White, 23% Black, 21% Hispanic, 4% Asian
Pre-ART CD4 <200 cells/µL30%
Mean follow-up duration7 years
Incident dementia cases618
Adjusted hazard ratio (aHR) for dementia with low pre-ART CD41.33 (95% CI: 1.13–1.57)
aHR for dementia with CD4 recovery to ≥500 cells/µL1.17 (95% CI: 0.85–1.60)

Key Findings

  • Low CD4 count (<200 cells/µL) before ART initiation is associated with a 33% increased risk of developing dementia in older adults with HIV.
  • Approximately 30% of the studied population had low pre-ART CD4 counts, indicating delayed diagnosis or treatment.
  • CD4 recovery to ≥500 cells/µL after ART initiation attenuates but does not fully eliminate the increased dementia risk.
  • Dementia diagnoses were reliably identified using validated ICD codes with high positive predictive value in this population.
  • The study controlled for sociodemographic and clinical confounders and accounted for competing risk of death in the analysis.

Clinical Implications

These findings underscore the importance of early HIV diagnosis and prompt initiation of ART to reduce long-term cognitive complications, including dementia. Clinicians should maintain assertive HIV screening strategies, especially in older adults, to prevent severe immunosuppression. Even with immune recovery, patients with prior low CD4 counts may require closer cognitive monitoring and supportive interventions.

Conclusion

Delayed HIV diagnosis or treatment, as evidenced by low pre-ART CD4 counts, is linked to a higher risk of dementia in older adults with HIV. Early detection and timely ART initiation remain critical to preserving cognitive health in this population.

References

  1. Study Authors/2024 -- Consequences of Postponed HIV Diagnosis and Treatment on the Likelihood of Dementia in Older Adults

Original Source(s)

Related Content